Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

Gelijkaardige items

• Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
  door: Moulis, Guillaume, et al.
  Gepubliceerd in: (2012)
• Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol)
  door: Tavassoli, Neda, et al.
  Gepubliceerd in: (2009)
• Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database
  door: Montastruc, Guillaume, et al.
  Gepubliceerd in: (2010)
• Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
  door: Berthet, Stephanie, et al.
  Gepubliceerd in: (2011)
• Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
  door: Montastruc, Jean-Louis, et al.
  Gepubliceerd in: (2020)